News
Dentsply Sirona (XRA) stock turns lower as Morgan Stanley downgrades to Equal Weight amid macro challenges, innovation concerns, and tariff risks. Read more here.
As previously reported, Morgan Stanley downgraded Dentsply Sirona (XRAY) to Equal Weight from Overweight with a price target of $14, down from ...
Zacks Investment Research on MSN1d
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio NowDENTSPLY SIRONA XRAY is well-positioned for growth due to its new digital-implant work flow and continued focus on research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback